Abstract
C Sixty Inc. is a private biopharmaceutical company focusing on the discovery and the development of a new class of therapeutics based on the fullerene molecule, a hollow sphere made up of 60 carbon atoms which was discovered in 1985 as the third and unprecedented new form of elemental carbon in nature. It was dubbed buckminsterfullerene (or fullerene) because of its geodesic character and its discoverers were awarded the 1996 Nobel Prize in chemistry. C Sixty’s lead products are based on modification of the fullerene molecule and include advanced products for the treatment of cancer, AIDS and neurodegenerative diseases. The company is also committed to a research, development and discovery program of novel biopharmaceuticals, diagnostics and medical devices for applications in diverse disease categories based on the unique molecular pincushion platform of the fullerene molecule. The company has a diverse proprietary intellectual portfolio which includes 5 issued and 3 new patent applications. The founding scientists of C Sixty Inc. include the undisputed world leaders in the application of fullerene to medicine, including the 1996 Nobel Prize winners in chemistry.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
Selected References
H. W. Kroto, J. R. Heath, R. F. Curl R. and E. Smalley, `A new form of elemental carbon —Buckminsterfullerene-C60’, Nature 318 (1985) 162–163.
W. Kratschner, L. D. Lab, K. Fostiropoulos and D. R. Huffman, `Solid C60 a new form of carbon’, ibid. 347 (1990) 354–358
A. W. Jensen, S. R. Wilso and D. I. Schuster, `Biological Applications of Fullerenes: A Review’, Biorg. Med. Chem. 4 (6) (1996) 767.
S. R. Wilson, `Biological Aspects of Fullerenes’, in “Fullerenes: Chemistry, Physics, and Technology”, edited by K. M. Kadish and R. S. Ruoff, ( John Wiley & Sons, New York, 2000 ) pp. 437–466.
R. P. Sijbesma, G. Srdanov, F. Wudl, J. A. Castoro, C. Wilkins, S. H. Friedman, D. L. DeCamp and G. L. Kenyon, `Synthesis of a Fullerene Derivative for the Inhibition of HIV Enzymes’, J. Am. Chem. Soc. 115 (1993) 6510.
M. Brettreich and A. Hirsch, `A highly water-soluble dendro[60] [fullerene’, Tetrahedron Lett. 27 (1998) 2731. D. I. Schuster, S. R. Wilson, A. N. Kirschner, R. F. Schinazi, S. Schlueter-Wirtz, T. Barnett, S. Martin
J. Ermolieff, J. Tang, M. Brettreich and A. Hirsch, `Evaluation of the Anti-HIV Potency of a Water-Soluble Dendrimeric Fullerene Derivative’, Electrochem. Soc. Proc. 2000–11 (2000) 250.
L. L. Dugan, D. M. Turetsky, C. Du, D. Lobner, M. Wheeler, C. R. Almli, C. K-F. Shen, T-Y. Luh, D. W. Choi and T-S. Lin, `Carboxyfullerenes as neuroprotective agents’, Proc. Natl. Acad. Sci. USA 94 (1997) 9434.
S. R. Wilson and D. I. Schuster, `Organic Chemistry of Fullerenes’, in “The Fullerene Handbook”, edited by K. Kadish and R. Ruoff, ( John Wiley & Sons, NY, 2000 ).
S. R. Wilson, `The Potential of Fullerenes in Biology and Medicine’, Proc. Electrochem. Soc. (1997) 321.
R. C. Richmond and U. J. Gibson, `Fullerene coated surfaces and uses thereof’, US Patent 5,310, 669 (1994).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Kluwer Academic Publishers
About this chapter
Cite this chapter
Sagman, U. (2002). Application and Commercial Prospects of Fullerenes in Medicine and Biology. In: Ōsawa, E. (eds) Perspectives of Fullerene Nanotechnology. Springer, Dordrecht. https://doi.org/10.1007/978-94-010-9598-3_13
Download citation
DOI: https://doi.org/10.1007/978-94-010-9598-3_13
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-9600-3
Online ISBN: 978-94-010-9598-3
eBook Packages: Springer Book Archive